Senior Director Global Regulatory Lead - Oncology
Full-timeSeniorOncology
$170K - $249K/yr(estimated)
Description
<p style="text-align:left">At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.</p><p style="text-align:inherit"></p><div><div><p><span><span>Purpose:</span> </span></p></div><div><p><span><span>The purpose of </span><span>the </span><span>Senior Director/Executive Director, </span><span>Global Regulatory Affairs, </span><span>Global Regulatory Lead </span><span>(GRL</span><span>) </span><span>role is to </span><span>develop</span><span> </span><span>and implement</span><span> </span><span>inn</span><span>ovative </span><span>global regulatory </span><span>strategies for </span><span>product(</span><span>s) in the assigned therapeutic area</span><span>. </span><span>The </span><span>GR</span><span>L</span><span> </span><span>is the accountable decision maker for the development & execution of global regulatory</span><span> strategies</span><span> </span><span>from portfolio entry to end of life cycle</span><span> to e</span><span>nsure strategies </span><span>meet </span><span>global </span><span>business </span><span>objective</span><span>s</span><span> </span><span>and </span><span>re</span><span>gional/local affiliate requirement</span><span>s</span><span>.</span></span><span> </span></p><p></p></div><div><p><span><span>The GRL </span><span>creates</span><span> and </span><span>leads the </span><span>Glo</span><span>bal </span><span>Regulatory Team</span><span> (</span><span>inclusive of GRA central function</span><span>s</span><span>, GRA-CMC</span><span>,</span><span> </span><span>GRA-Devices</span><span>,</span><span> and regional regulatory scientists</span><span>)</span><span> </span><span>and </span><span>is responsible for</span><span> forming and </span><span>maintaining</span><span> a</span><span> </span><span>highly </span><span>effective global regulatory tea</span><span>m</span><span>. </span><span>The GRL </span><span>is responsible </span><span>for</span><span> the </span><span>creation and maintenance of the Regulatory Strategy Document </span><span>(RSD) </span><span>and</span><span> ensure</span><span>s</span><span> local plans</span><span>, created by the regional regulatory teams,</span><span> are </span><span>aligned to the </span><span>Global Brand Development</span><span> (GBD)</span><span>/global program</span><span> team and </span><span>business priorities in terms o</span><span>f the program’s value proposition, </span><span>workflow</span><span>, product labeling, risk management, and issues</span><span> management</span><span>.</span><span> </span><span>Accordingly</span><span>, the GRL</span><span> is the primary interface </span><span>with </span><span>and</span><span> will </span><span>represent</span><span> GRA on </span><span>GBD</span><span>/global program</span><span> team to ensure global input into</span><span> development plans</span><span>, provide solutions</span><span> (</span><span>created</span><span> with the regulatory team)</span><span> to development and regulatory barriers</span><span>, and reflect and manage risks</span><span>. </span><span>The GRL </span><span>will </span><span>represent</span><span> regional regulatory plans </span><span>to the GBD</span><span>/globa</span><span>l program </span><span>team and at stakeholder/governance meetings </span><span>and </span><span>is responsible </span><span>to </span><span>include</span><span> GRA functional and regional experts</span><span> </span><span>as needed to inform development and manage issues.</span></span><span> </span></p><p></p></div><div><p><span><span>For </span><span>preclinical and </span><span>early </span><span>clinical development</span><span> programs, </span><span>the GRL </span><span>leads the US</span><span> </span><span>submission</span><span>s</span><span> and agency interactions</span><span>. </span><span>All other agency interactions</span><span> will be the responsibility of the regional regulatory scientists.</span></span><span> </span></p></div><div><p></p><p><span><span>Primary Responsibilities:</span></span><span><span> </span></span></p></div><div><p><b><span>Regulatory and Scientific Expertise</span></b><span> </span></p></div><div><p><i><span>Develop, </span></i><i><span>Update and Execute </span><span>the Global Regulatory </span><span>Strategy</span><span> - </span><span>Initiate and Update Regulatory Strategy Document</span><span> (RSD)</span></i><span> </span></p></div><div><ul><li><span><span>Obtain input from the </span><span>global regulatory team</span><span> members to develop a global regulatory strategy which supports product</span><span> (including delivery device and relevant medical devices)</span><span> development, registration</span><span>,</span><span> and lifecycle maintenance</span><span> globally</span><span>. </span><span>Ensure regulatory strategy </span><span>is </span><span>integrated into the development team plan from Candidate Selection to End of Product Lifecyle (including NILEX)</span><span>. </span><span>Develop and implement </span><span>innovative approaches</span><span> and </span><span>solutions,</span><span> and </span><span>drive </span><span>acceleration strategies</span><span>. </span><span>Identify</span><span> and</span><span> effectively</span><span> communicate regulatory risks</span><span>.</span></span><span> </span></li><li><span><span>Lead </span><span>Global </span><span>Regulatory </span><span>T</span><span>eam in the development of </span><span>RSD</span><span>(s) for assigned programs</span><span>. </span><span>Initiate and</span><span> </span><span>maintain</span><span> </span><span>regulatory</span><span> </span><span>strategy</span><span> </span><span>documents</span><span> by</span><span> </span><span>leveraging</span><span> </span><span>team </span><span>expertise</span><span>, as well as </span><span>scientific, drug/device clinical development and </span><span>knowledge</span><span> </span><span>from</span><span> </span><span>health authorities</span><span> such as regulatory policies, regulatory precedents, trends</span><span>, and emerging regulatory science</span><span>.</span><span> </span><span>Integrate</span><span> </span><span>information</span><span> </span><span>from</span><span> </span><span>the </span><span>external</span><span> </span><span>environment,</span><span> </span><span>product</span><span> </span><span>specific</span><span> </span><span>regulator</span><span> </span><span>advice,</span><span> </span><span>and</span><span> </span><span>other</span><span> </span><span>public</span><span> </span><span>information</span><span> </span><span>(</span><span>i.e.</span><span> </span><span>Advisory</span><span> </span><span>Committees)</span><span> to </span><span>develop</span><span> </span><span>robust, innovative</span><span> </span><span>regulatory</span><span> </span><span>strategies</span><span> and solutions.</span><span> </span></span><span> </span></li><li><span><span>Provide input for and a</span><span>ttend key regulatory agency meetings, as needed, that could </span><span>impact</span><span> the global product strategy or brand. </span></span><span> </span></li><li><span><span>Enable discussion of the RSD and regulatory issues/challenges at the Regulatory Strategy Forum together with </span><span>G</span><span>lobal </span><span>R</span><span>egulatory </span><span>T</span><span>eam.</span></span><span> </span></li><li><span><span>Continually expand therapeutic area knowledge</span><span>. </span><span>Monitor and assess impact of relevant global regulations, guidance, and current regulatory environment</span><span>.</span><span> </span><span>Monitor upcoming</span><span> </span><span>and recent</span><span> </span><span>approvals</span><span> </span><span>of competitive development</span><span> </span><span>programs/plans</span><span>.</span></span><span> </span></li><li><span><span>Ensure </span><span>strategic messaging and content of global regulatory submission documents. </span><span>Provide regulatory direction in the development of the core data sheet</span><span> and </span><span>claims mapping </span><span>to align commercial </span><span>objectives</span><span> in the context of available and expected scientific data, regulatory guidance</span><span>,</span><span> and precedent</span><span>.</span></span><span> </span></li><li><span><span>Ensures local strategies and solution </span><span>deliver to the </span><span>global </span><span>regulatory </span><span>strategy and </span><span>meets BU and brand</span><span> </span><span>goals</span><span>.</span></span><span> </span></li><li><span><span>Provide </span><span>timely</span><span> and effective</span><span> communication updates to </span><span>the GBD teams and </span><span>BU </span><span>management and other internal stakeholders</span><span>, as </span><span>appropriate</span><span>.</span></span><span> </span></li></ul></div><div><p><span> </span></p></div><div><p><i><span>Lead Global Regulatory Team</span></i><span> </span></p></div><div><ul><li><span><span>Lead </span><span>G</span><span>lobal </span><span>R</span><span>egulatory </span><span>T</span><span>eam consisting of regional regulatory scientists, GRA-CMC, </span><span>GRA-Device</span><span>s</span><span>, </span><span>GRA-</span><span>RD</span><span>&</span><span>E, </span><span>and GRA-Global Labeling and Product Communications</span><span>. Ensures clear and transparent two-way communication between </span><span>GBD</span><span>/</span><span>g</span><span>lobal </span><span>p</span><span>rogram </span><span>t</span><span>eam and </span><span>Global</span><span> Regulatory Team</span><span>.</span></span><span> </span></li><li><span><span>C</span><span>oach and </span><span>facilitate</span><span> a feedback culture within the Global Regulatory Team </span><span>to</span><span> develop team performance</span><span>.</span></span><span> </span></li></ul></div></div><div><div><ul><li><span><span>Communicate and share key information to enable seamless execution of </span><span>global</span><span> regulatory strategy</span><span> and cross</span><span>-functional shared learnings</span><span>.</span></span><span> </span></li></ul></div><div><p><span> </span></p></div><div><p><i><span>Represent </span><span>R</span><span>egulatory </span><span>on</span><span> the </span><span>GBD/</span><span>Global </span><span>Program</span><span> Team</span></i><span> </span></p></div><div><ul><li><span><span>Support development teams in strategic planning, trial design and registration strategies for all in-scope countries for </span><span>assigned </span><span>product</span><span>s/programs</span><span>, bringing in regional, CMC and Device regulatory scientists as needed</span><span>.</span><span> </span></span><span> </span></li><li><span><span>C</span><span>onsistently </span><span>c</span><span>ommunicate well defined, successful regulatory strategies throughout the organization</span><span>.</span></span><span> </span></li></ul></div><div><p><span> </span></p></div><div><p><i><span>For </span><span>Preclinical and Early Clinical Development</span><span> Programs: </span><span>Lead and develop the </span><span>US </span><span>strategy for submission and amendments for IND and IDE</span></i></p></div><div><ul><li><span><span>Determine</span><span> </span><span>and </span><span>communicate</span><span> </span><span>submission</span><span> and</span><span> </span><span>approval</span><span> </span><span>requirements and regulator expectations</span><span>.</span></span><span> </span></li><li><span><span>Generate</span><span> </span><span>regulatory</span><span> </span><span>documents</span><span> </span><span>and e</span><span>nsure</span><span> </span><span>the</span><span> </span><span>regulatory</span><span> </span><span>documents</span><span> </span><span>contain</span><span> </span><span>appropriate</span><span> </span><span>data/information</span><span> based on </span><span>regulator</span><span> expectations </span><span>and</span><span> </span><span>are </span><span>clearly</span><span> written </span><span>to</span><span> </span><span>articulate</span><span> </span><span>Lilly’s</span><span> scientific </span><span>position.</span></span><span> </span></li><li><span><span>Anticipate</span><span>, </span><span>resolve, and communicate</span><span> </span><span>key</span><span> </span><span>technical,</span><span> </span><span>operational,</span><span> </span><span>and</span><span> </span><span>strategic</span><span> </span><span>issues</span><span> </span><span>that</span><span> may</span><span> </span><span>impact</span><span> </span><span>other development </span><span>function</span><span>s</span><span> </span><span>or </span><span>the</span><span> </span><span>development</span><span> </span><span>team.</span></span><span> </span></li><li><span><span>Propose innovative solutions</span><span> to regulatory issues to meet the business </span><span>objectives</span><span> while </span><span>maintaining</span><span> compliance with applicable regulations and internal quality systems.</span></span><span> </span></li><li><span><span>Own relationship and interaction strategy with US FDA</span></span><span> </span></li><li><span><span>Execute</span><span> </span><span>high</span><span> </span><span>quality</span><span> </span><span>communications</span><span> </span><span>with</span><span> </span><span>FDA </span><span>and </span><span>internal</span><span> stakeholders </span><span>to </span><span>articulate</span><span> and ensure understanding of </span><span>the</span><span> </span><span>regulatory</span><span> </span><span>strategy</span><span> </span><span>and </span><span>complex</span><span> </span><span>issues.</span><span> </span></span><span> </span></li><li><span><span>Accountable</span><span> </span><span>for</span><span> </span><span>communications</span><span> </span><span>to </span><span>the</span><span> </span><span>regulator,</span><span> </span><span>development</span><span> </span><span>teams,</span><span> </span><span>GRA, </span><span>other development functions</span><span>, Research, and BU leadership.</span><span> </span></span><span> </span></li></ul></div><div><p></p><p><i><span>Engage in, influence, and shape external environment initiatives related to portfolio assets</span></i><span> </span></p></div><div><ul><li><span><span>Creates and fosters strategic </span><span>relationship</span><span> with key external players to </span><span>identify</span><span> and </span><span>anticipate</span><span> opportunities for growth.</span></span><span> </span></li></ul></div><div><p><span> </span></p></div><div><p><i><span>Review corporate communications press releases</span></i><span> </span></p></div><div><ul><li><span><span>Set </span><span>appropriate</span><span> </span><span>direction</span><span> with Global Marketing and </span><span>GBD</span><span> team</span><span> </span><span>for</span><span> </span><span>development, review, and approval of promotional claims</span><span>.</span></span><span> </span></li></ul></div></div><div><div><ul><li><span><span>Partner with Regulatory </span><span>Product Communications </span><span>reviewer to advise </span><span>GB</span><span>D team</span><span> on promotional strategy</span><span>.</span><span> </span></span><span> </span></li><li><span><span>Partner with Regulatory </span><span>Product Communications</span><span> reviewer to review </span><span>and </span><span>approve press materials and IR communications.</span><span> </span></span><span> </span></li></ul></div><div><p></p><p><b><span>Lead/Influence/Partner</span></b><span> </span></p></div><div><ul><li><span><span>Exemplify Team Lilly behaviors: Include, Innovate, Accelerate,</span><span> and</span><span> Deliver in internal and external interactions</span><span>.</span></span><span> </span></li><li><span><span>Model the innovatio</span><span>n,</span><span> leadership behaviors and regulatory excellence attributes as described in Global Regulatory Affairs white papers.</span></span><span> </span></li><li><span><span>Participate</span><span> </span><span>in </span><span>forums</span><span> </span><span>that</span><span> </span><span>share</span><span> </span><span>regulatory</span><span> </span><span>information</span><span> </span><span>across</span><span> </span><span>GRA components and other Lilly teams and business partners</span><span>.</span></span><span> </span></li><li><span><span>Constructively</span><span> </span><span>challenge</span><span> </span><span>teams</span><span> to </span><span>reach</span><span> </span><span>the</span><span> </span><span>best solutions</span><span> to</span><span> </span><span>issues</span><span>.</span></span><span> </span></li><li><span><span>Serve as a mentor for GRA personnel</span><span>.</span><span> </span></span><span> </span></li><li><span><span>May have direct reports</span><span>.</span></span><span> </span></li></ul><p></p><div><div><p><b><span><span>Minimum Qualification Requirements:</span></span><span> </span></b></p></div><div><ul><li>Advanced scientific degree (i.e., PhD, PharmD) and 8+ years Industry-related experience in regulatory affairs and/or drug development experience</li></ul><p><b>OR</b></p><ul><li><span>Bachelor’s degree with 10+ years of industry-related experience in regulatory affairs and/or drug development experience</span></li></ul></div><div></div><div><p></p><p><b><span><span>Other Information/Additional Preferences:</span></span><span> </span></b></p></div><div><p></p><ul><li>Proven experiences and leadership assignments demonstrating bold leadership, exemplary team attributes, effective communications with peers and executive leaders, and effective conflict management skills</li><li><span><span>Travel<span> </span>expected<span> </span>(10-15%)</span> </span></li><li><span><span>Experience in regulatory submissions and regulatory interactions in the US, EU, </span><span>China</span><span> and Japan</span></span><span> </span></li><li><span><span>Previous</span><span> regulatory or leadership assignments </span><span>across multiple countries</span></span><span> </span></li><li><span><span>Industry-related</span><span> </span><span>experience</span><span> </span><span>in </span><span>regulatory</span><span> </span><span>affairs</span><span> </span><span>and/or</span><span> </span><span>drug</span><span> </span><span>development</span><span> </span><span>experience</span><span> </span><span>for </span><span>10</span><span> </span><span>years</span></span><span> </span></li><li><span><span>Direct experience in clinical and CMC regulatory sciences</span></span><span> </span></li><li><span><span>Experience in </span><span>applicable </span><span>therapeutic area </span></span><span> </span></li><li><span><span>Knowledge</span><span> of</span><span> </span><span>Global regula</span><span>tory</span><span> procedures</span><span> </span><span>and </span><span>practices</span><span> </span><span>a</span><span>nd</span><span> </span><span>awareness</span><span> </span><span>of</span><span> </span><span>evolving</span><span> </span><span>regulatory</span><span> </span><span>reform</span><span> </span><span>initiatives </span></span></li><li><span><span>Demonstrated</span><span> </span><span>deep</span><span> </span><span>knowledge</span><span> of</span><span> </span><span>the</span><span> </span><span>integrated </span><span>drug</span><span> </span><span>development</span><span> </span><span>process</span><span> and</span><span> </span><span>Lilly</span><span>’s</span><span> </span><span>(or external peer company) </span><span>regulatory/business</span><span> </span><span>strategies</span><span> </span></span><span> </span></li><li><span><span>Demonstrated</span><span> ability to find solutions and alternatives </span><span>through </span><span>teamwork,</span><span> </span><span>resulting in </span><span>positive business outcomes</span></span><span> </span></li><li><span><span>Demonstrated</span><span> </span><span>ability</span><span> </span><span>to</span><span> </span><span>assess</span><span> </span><span>and</span><span> </span><span>manage</span><span> risk</span><span> </span><span>in a</span><span> </span><span>highly</span><span> </span><span>regulated</span><span> </span><span>environment</span></span><span> </span></li><li><span><span>S</span><span>trong</span><span> </span><span>written,</span><span> </span><span>spoken</span><span> and</span><span> </span><span>presentation</span><span> </span><span>communication</span></span><span> </span></li><li><span><span>Demonstrated</span><span> </span><span>negotiation</span><span> </span><span>and</span><span> </span><span>influence</span><span> </span><span>skills</span></span><span> </span></li><li><span><span>Demonstrated</span><span> </span><span>attention</span><span> </span><span>to </span><span>detail</span></span></li></ul></div></div></div></div><p style="text-align:left">Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (<a target="_blank" href="https://careers.lilly.com/us/en/workplace-accommodation"><span><span><span class="WCO0">https://careers.lilly.com/us/en/workplace-accommodation</span></span></span></a>) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.</p><p style="text-align:inherit"></p><p style="text-align:left">Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.</p><p style="text-align:left"><br />Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia Network, Black Employees at Lilly, Chinese Culture Network, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ+ Allies), Veterans Leadership Network (VLN), Women’s Initiative for Leading at Lilly (WILL), enAble (for people with disabilities). Learn more about all of our groups.</p><p style="text-align:inherit"></p><p style="text-align:inherit"></p><p style="text-align:left">Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is</p>$169,500 - $248,600<p style="text-align:inherit"></p><h3></h3><p style="text-align:left">Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.</p><p style="text-align:inherit"></p><p style="text-align:left">#WeAreLilly</p>
Eli Lilly and Company
PHARMACEUTICAL
Biologics Discovery
LocationINDIANAPOLIS, IN
Employees43,000
Open Jobs856
DiabetesOncologyNeuroscienceImmunology
View Company ProfilePipeline
Glucagon receptor antagonist LY2409021N/A
LY2503029N/A
SelpercatinibN/A
Treatment for FibromyalgiaN/A
There are no interventions in this study. All participants complete online surveys.N/A